Semi-Annual Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7324025

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
9,796,000,000 JPY
10,065,000,000 JPY
8,580,000,000 JPY
6,817,000,000 JPY
Depreciation
2,596,000,000 JPY
2,546,000,000 JPY
Impairment losses
19,000,000 JPY
1,863,000,000 JPY
Interest and dividend income
-479,000,000 JPY
-439,000,000 JPY
Interest expenses
17,000,000 JPY
17,000,000 JPY
Loss (gain) on sale of property, plant and equipment
0 JPY
0 JPY
Decrease (increase) in trade receivables
-4,559,000,000 JPY
972,000,000 JPY
Decrease (increase) in inventories
-1,603,000,000 JPY
-583,000,000 JPY
Increase (decrease) in trade payables
880,000,000 JPY
280,000,000 JPY
Other, net
-936,000,000 JPY
1,746,000,000 JPY
Subtotal
5,903,000,000 JPY
13,240,000,000 JPY
Interest and dividends received
479,000,000 JPY
439,000,000 JPY
Interest paid
-17,000,000 JPY
-17,000,000 JPY
Net cash provided by (used in) operating activities
2,577,000,000 JPY
9,253,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,861,000,000 JPY
-1,987,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
12,000,000 JPY
Purchase of investment securities
JPY
-200,000,000 JPY
Proceeds from sale of investment securities
516,000,000 JPY
5,000,000 JPY
Other, net
-22,000,000 JPY
-18,000,000 JPY
Net cash provided by (used in) investing activities
-5,854,000,000 JPY
-2,627,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,657,000,000 JPY
-5,649,000,000 JPY
Net cash provided by (used in) financing activities
-5,658,000,000 JPY
-6,990,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-8,935,000,000 JPY
-364,000,000 JPY
Cash and cash equivalents
65,325,000,000 JPY
74,260,000,000 JPY
74,625,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.